Professor Adrienne Flanagan, co-senior author of the study from UCL Cancer Institute and a Consultant Histopathologist at RNO Dr. Solange De Noon, co-first author of the study from UCL Cancer ...

Professor John Bridgewater, UCL Cancer Institute clinical researcher and UCLH consultant medical oncologist, who will lead the UK arm of the trial, said: "These cancers are becoming more common.

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...

In the new study, patients diagnosed with the three main types of bile duct cancer (intrahepatic, perihilar or distal ...

UCLH consultant medical oncologist and UCL Cancer Institute clinical researcher, Professor John Bridgewater commented on the grim prospects for current standard cancer care, stating: "With the ...

The institute is a partnership between Cancer Research UK, Imperial College London, King's College London (KCL), the Medical Research Council, University College London (UCL) and the Wellcome Trust.

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumour DNA can predict lung cancer outcome in a Cancer Research UK-funded study.

UCLH consultant medical oncologist and UCL Cancer Institute clinical researcher Professor John Bridgewater said: “With the current standard of care, patients typically only live for one year ...